bridge7 Oncology logo

bridge7 Oncology

Bridge7 uses AI to scale clinical expertise to improve the efficiency, consistency and quality of delivering cancer care

4 employees · est. 2017 · Toronto, Canada

VS
Fore Biotherapeutics logo

Fore Biotherapeutics

A precision oncology company rooted in science and innovation, developing cancer therapies guided by functional genomics

46 employees · est. 2011 · Philadelphia, United States

Fore Biotherapeutics is the older company (2017 vs 2011); Fore Biotherapeutics is the larger of the two.

Side-by-Side Comparison

bridge7 Oncology Fore Biotherapeutics
Founded
2017 2011 older
Headquarters
Toronto, Canada Philadelphia, United States
Employees
4 46 larger
Industry
AI, Health Care Biotechnology, Health Care
Funding Stage
Seed Series D
Total Funding
Not tracked yet $166.50M
Funding Rounds
3 9
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Clinical Expertise, Cancer Care, Oncology, Precision Medicine Precision Oncology, Cancer Therapies, Functional Genomics, Science, Innovation, Precision Medicine, Oncology Research, Drug Development, Cancer Treatment, Precision Medicine Company
Website
bridge7.ai fore.bio
bridge7 Oncology logo

About bridge7 Oncology

\\Bridge7 Oncology\ is a Canadian startup founded in 2017\ with a focus on revolutionizing cancer care. Their slogan, "Bridge7 uses AI to scale clinical expertise to improve the efficiency, consistency and quality of delivering cancer care\," reflects their mission to bridge the gap between limited...

Fore Biotherapeutics logo

About Fore Biotherapeutics

Fore Biotherapeutics is a biotechnology startup based in the United States, founded in 2011. The company's slogan, "A precision oncology company rooted in science and innovation, developing cancer therapies guided by functional genomics," reflects its dedication to developing cancer therapies guided...

We will tell you when either one moves

BounceWatch watches bridge7 Oncology and Fore Biotherapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at bridge7 Oncology and Fore Biotherapeutics — by email.

Frequently Asked Questions

bridge7 Oncology — Bridge7 uses AI to scale clinical expertise to improve the efficiency, consistency and quality of delivering cancer care. Fore Biotherapeutics — A precision oncology company rooted in science and innovation, developing cancer therapies guided by functional genomics. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
bridge7 Oncology has raised undisclosed funding while Fore Biotherapeutics has raised $166.50M.
bridge7 Oncology and Fore Biotherapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare bridge7 Oncology with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at bridge7 Oncology on 12 Sep 2024, and Fore Biotherapeutics on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes